DMD and Duchenne muscular dystrophy: Several sources of cardiac disease heterogeneity have been delineated in patients with DMD, including cardiac medication (moderate- to high-quality evidence), DMD mutations (low/very low-quality evidence), DMD genetic modifiers (low-quality evidence), glucocorticoid exposure (high-quality evidence), muscle strength (low-quality evidence), and ventilation support (low-quality evidence).